Inhibition of the interaction between NS3 protease and HCV IRES with a small peptide: a novel therapeutic strategy.
about
A unique phosphorylation-dependent eIF4E assembly on 40S ribosomes co-ordinated by hepatitis C virus protein NS5A that activates internal ribosome entry site translation.AVP-IC50 Pred: Multiple machine learning techniques-based prediction of peptide antiviral activity in terms of half maximal inhibitory concentration (IC50).Induction of Transcriptional Gene Silencing by Expression of shRNA Directed to c-Myc P2 Promoter in Hepatocellular Carcinoma by Tissue-Specific Virosomal Delivery.
P2860
Inhibition of the interaction between NS3 protease and HCV IRES with a small peptide: a novel therapeutic strategy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Inhibition of the interaction ...... a novel therapeutic strategy.
@en
Inhibition of the interaction ...... a novel therapeutic strategy.
@nl
type
label
Inhibition of the interaction ...... a novel therapeutic strategy.
@en
Inhibition of the interaction ...... a novel therapeutic strategy.
@nl
prefLabel
Inhibition of the interaction ...... a novel therapeutic strategy.
@en
Inhibition of the interaction ...... a novel therapeutic strategy.
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of the interaction ...... a novel therapeutic strategy.
@en
P2093
Agnel P Joseph
Anuj Kumar
Chaitrali L Roy
Debi P Sarkar
N Srinivasan
Prashant Mani
Saumitra Das
Upasana Ray
P2860
P356
10.1038/MT.2012.151
P577
2012-08-21T00:00:00Z